Cross-Sector entity
CDC is the most frequent co-covered peer, appearing in 2 of the 2 tracked stories. Coverage clusters in pharma, which accounts for 1 of those 2, with the remainder spread across 1 other category. We currently track 2 Cross-Sector stories that mention Infant Botulism, all published on June 15, 2026.
2 verified stories tracked
Last mentioned: Jun 15, 2026
Entity pulse
Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
CDC is the most frequent co-covered peer, appearing in 2 of the 2 tracked stories. Coverage clusters in pharma, which accounts for 1 of those 2, with the remainder spread across 1 other category. We currently track 2 Cross-Sector stories that mention Infant Botulism, all published on June 15, 2026. Each carries 2 original sources on average.
Computed from the 2 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Infant Botulism. Shared-story counts are live from our verified record — not editorial picks.
Three infants in three states were diagnosed with botulism after consuming Nara Organics powdered formula, prompting a voluntary recall of all whole milk formula. All babies recovered, but the FDA and CDC investigation highlights risks of powdered formula for newborns and emphasizes clinical vigilance among pediatricians.
A cluster of three infant botulism cases, despite zero positive C. botulinum tests in product lots, has forced Nara Organics to recall all whole milk powdered formula. The incident raises critical quality control and sterility challenges for the organic infant nutrition sector.
Source: newson6.com · cbsnews.com
